Why Southeast Asia’s healthtech startups struggle to attract investment despite the AI boom
Artificial intelligence is attracting serious investment across Southeast Asia. Startups are using it to automate business processes, develop new products, and solve problems that once required large engineering teams. Healthcare should be a natural beneficiary. AI can assist with clinical documentation, diagnostics, administrative tasks, and remote care. Yet the region’s healthtech funding…
Southeast Asia's healthtech startups are struggling to attract investment despite the AI boom in the region. While AI is attracting serious investment across Southeast Asia and healthcare startups are exploring its potential in areas such as clinical documentation, diagnostics, and remote care, the funding for healthtech has declined significantly from US$397 million in 2023 to US$59.7 million in 2025.
This discrepancy highlights the challenges healthtech founders face in demonstrating commercial viability to investors. Despite the innovative potential of AI in healthcare, investors demand concrete answers regarding the product's commercial viability, including who will pay for it, how long it will take to acquire healthcare customers, and evidence of its clinical value.
Healthcare startups must prove that their AI solutions can integrate seamlessly into existing workflows, reduce administrative work, improve documentation quality, and ultimately generate recurring revenue without continuous funding.
Brief written by urgent.news from e27's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
